Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug for treating ascites due to cirrhosis

A technology for liver cirrhosis ascites and drugs, applied in the directions of drug combination, digestive system, pharmaceutical formula, etc., can solve the problems of affecting heart and lung function, affecting liver and kidney function, liver and kidney damage, etc. good effect

Inactive Publication Date: 2018-03-23
梁雷
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the existence of a large amount of ascites, on the one hand, ascites can easily oppress the heart and lungs and affect the function of the heart and lungs; at the same time, because of the existence of a large amount of ascites, it is easy to cause bacterial growth, which is prone to spontaneous peritonitis; on the other hand, it can also cause liver and kidney damage. Ascites can cause insufficient effective blood volume and insufficient blood supply to vital organs such as the liver and kidneys, thereby affecting liver and kidney functions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] A medicine for treating liver cirrhosis ascites, which is prepared from the following raw materials in parts by weight: 10 parts of turtle shell, 16 parts of Codonopsis pilosula, 10 parts of Atractylodes macrocephala, 10 parts of Polyporus chinensis, 10 parts of Bupleurum chinensis, 10 parts of Gallus gallis, 10 parts of aconite, 5 parts of cinnamon, 5 parts of capillary, 5 parts of salvia, 8 parts of angelica, 8 parts of winter melon seeds, 8 parts of plantain seed, and 10 parts of gall grass.

Embodiment 2

[0016] A medicine for treating liver cirrhosis ascites, which is prepared from the following raw materials in parts by weight: 12 parts of turtle shells, 17 parts of Codonopsis pilosula, 12 parts of Atractylodes macrocephala, 12 parts of Polyporus chinensis, 12 parts of Bupleurum chinensis, 12 parts of gallinaceous gold, 12 parts of aconite, 6 parts of cinnamon, 6 parts of capillary, 6 parts of salvia, 9 parts of angelica, 9 parts of winter melon seeds, 9 parts of plantain seed, and 13 parts of gall grass.

Embodiment 3

[0018] A medicine for treating liver cirrhosis ascites, which is made from the following raw materials in parts by weight: 12.5 parts of turtle shell, 18 parts of Codonopsis pilosula, 12.5 parts of Atractylodes macrocephala, 12.5 parts of polyporus, 12.5 parts of bupleurum, 12.5 parts of gallinaceous gold, 12.5 parts of aconite, 6.5 parts of cinnamon, 6.5 parts of capillary, 6.5 parts of salvia, 10 parts of angelica, 10 parts of winter melon seeds, 10 parts of plantain seed, 15 parts of gall grass.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating liver cirrhosis ascites, which is prepared from the following raw materials in parts by weight: 10-15 parts of turtle shell, 16-20 parts of Codonopsis pilosula, 10-15 parts of Atractylodes macrocephala, 10-15 parts of polyporus, and 10 parts of Bupleurum ‑15 servings, 10‑15 servings of gallinaceous gold, 10‑15 servings of aconite, 5‑8 servings of cinnamon, 5‑8 servings of capillary, 5‑8 servings of salvia miltiorrhiza, 8‑12 servings of angelica, 8‑12 servings of winter melon seeds, 8-12 parts of Semen psyllium, 10-20 parts of gall grass. The present invention adopts the medicine prepared from traditional Chinese medicines such as turtle shell, Codonopsis pilosula, Atractylodes macrocephala, Polyporus, Bupleurum, Gallinarum, etc., each raw material interacts and affects each other, has the effects of invigorating the spleen and warming the kidney, removing blood stasis and promoting water flow, and can effectively treat Ascites due to cirrhosis of the liver, and natural medicines are used for each raw material medicine, so it has the advantages of quick effect, good curative effect, and no toxic and side effects.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a medicine for treating liver cirrhosis ascites. Background technique [0002] Cirrhotic ascites is the most common clinical symptom in the decompensated stage of cirrhosis. Once ascites occurs in cirrhosis, it often indicates serious damage to liver function and poor prognosis. Modern medicine believes that liver cirrhosis is a common chronic disease, which can be caused by one or more pathogenic factors acting on the liver for a long time or continuously. Nodular regeneration and massive fibrosis of connective tissue lead to structural disorder of the hepatic lobules, forming pseudolobules, resulting in hardening of the liver texture and eventually developing into cirrhosis. [0003] Ascites is the most common initial event when liver cirrhosis is decompensated, and the occurrence of ascites is an important sign of decompensation in the natura...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/714A61P1/16A61P7/10A61K35/586A61K35/57
CPCA61K36/714A61K35/57A61K35/586A61K36/07A61K36/232A61K36/233A61K36/28A61K36/282A61K36/284A61K36/344A61K36/42A61K36/515A61K36/537A61K36/54A61K36/68A61K2300/00
Inventor 梁雷
Owner 梁雷
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products